Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses (Details 4)

v2.4.0.6
Acquisitions, Investments, and Licenses (Details 4) (FineTech And Opko Diagnostics [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
FineTech And Opko Diagnostics [Member]
   
Pro forma result of the combined companies    
Revenue $ 36,238 $ 34,102
Loss from continuing operations (20,879) (12,606)
Net loss attributable to common shareholders $ (1,368) $ (23,295)
Basic and diluted loss from continuing operations per share $ 0.00 $ (0.08)
Basic and diluted loss from discontinued operations per share $ 0.00 $ (0.04)
Basic and diluted loss per share $ 0.00 $ (0.12)